In a real-world study, In the end, researchers compared 395 ALS patients who'd been given Radicava against 395 matched ...

Masitinib is an oral inhibitor of tyrosine kinases, enzymes important for immune cells thought to drive ALS inflammation and ...

Ncardia’s iPSC-derived microglia may aid ALS research and help to screen new therapies that target inflammation in ALS.

The genes included those involved in the function of energy-producing mitochondria, lipid and iron metabolism, and the ...

Columnist Dagmar Munn turns to affirmations and positive self-talk on those occasional days when she feels shut down.

New York was the only state to receive the highest mark on the ALS Association’s latest report cards, the association said.

ALS is a disease of continual losses and trade-offs. We walk a tightrope between safety and independence, and caution and quality of life.